Synopsys INC Form 4 insider transactions

NASDAQ
Chief Revenue Officer of Synopsys, Richard Mahoney, reports the acquisition and disposal of company stock and restricted stock units.
NASDAQ
Synopsys' Chief Accounting Officer, Sudhindra Kankanwadi, disposed of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Synopsys has entered into a definitive agreement to sell its Optical Solutions Group (OSG) to Keysight Technologies, contingent on regulatory approvals and the successful closing of Synopsys' acquisition of Ansys.
NASDAQ
Synopsys CEO Sassine Ghazi reports the disposition and acquisition of common stock and restricted stock units to cover tax obligations.
NASDAQ
John F. Runkel Jr., GC & Corporate Secretary of Synopsys Inc., reports acquiring 35 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
Richard S. Mahoney, Chief Revenue Officer of Synopsys Inc., acquired 22 shares of common stock through the company's Employee Stock Purchase Plan on August 30, 2024.
NASDAQ
Sudhindra Kankanwadi, Chief Accounting Officer of Synopsys Inc., reports the acquisition of 35 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
Shelagh Glaser, CFO of Synopsys Inc, acquired 32 shares of common stock under the company's Employee Stock Purchase Plan on August 30, 2024.
NASDAQ
Synopsys CEO Sassine Ghazi acquired 22 shares of common stock through the company's Employee Stock Purchase Plan on August 30, 2024.
NASDAQ
Aart de Geus, Executive Chair of Synopsys Inc., reports acquiring 22 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
Synopsys CEO Sassine Ghazi exercised stock options and sold shares on August 23, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Aart de Geus, Executive Chair of Synopsys, reports the exercise of stock options and sale of shares, along with a transfer of shares between trusts.
NASDAQ
Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on July 10th and 11th, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on July 5th and July 8th, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on July 2nd and 3rd, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares in multiple transactions on June 28, 2024, and July 1, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares of common stock on June 26 and 27, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares of common stock on June 24 and 25, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Richard S. Mahoney, Chief Revenue Officer of Synopsys Inc., reported the sale of 3,316 shares of common stock on June 18, 2024, at a price of $611.41 per share.
NASDAQ
Richard Mahoney, Chief Revenue Officer of Synopsys Inc., reported the disposition and acquisition of common stock and restricted stock units to cover tax obligations.
NASDAQ
John F. Runkel, Jr., GC & Corporate Secretary of Synopsys Inc., reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Director Mercedes Johnson transferred 1,697 shares of Synopsys Inc. common stock into the Mercedes Johnson Trust on May 28, 2024.
NASDAQ
Synopsys CEO Sassine Ghazi exercised stock options and sold shares on May 24, 2024, according to a Form 4 filing with the SEC.
NASDAQ
John F. Runkel, Jr., GC & Corporate Secretary of Synopsys Inc., reports exercising stock options and selling shares on May 24, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Synopsys' acquisition of Ansys faces a potential delay due to a notification requirement from Chinese regulators, with the transaction still expected to close in the first half of 2025.
NASDAQ
Synopsys' acquisition of Ansys may be delayed as Chinese regulators acknowledge the transaction but require notification.
NASDAQ
Ansys supplements its proxy statement with additional disclosures to address stockholder demands challenging the adequacy of information provided in connection with the proposed merger with Synopsys.
NASDAQ
Director Luis Borgen reports acquisition of 356 shares of Synopsys common stock through an automatic award under the company's equity incentive plan.
NASDAQ
Director Roy Vallee reports acquisition of 356 shares of Synopsys Inc. stock and indirect ownership of 20,000 shares through a partnership.
NASDAQ
Director John Schwarz reports acquisition of 356 shares of Synopsys common stock on April 10, 2024, through an automatic award under the company's 2017 Non-Employee Directors Equity Incentive Plan.